BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ragnarsson-Olding BK, Karsberg S, Platz A, Ringborg UK. Mutations in the TP53 gene in human malignant melanomas derived from sun-exposed skin and unexposed mucosal membranes. Melanoma Res 2002;12:453-63. [PMID: 12394187 DOI: 10.1097/00008390-200209000-00007] [Cited by in Crossref: 43] [Cited by in F6Publishing: 32] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Ha JH, Lee C, Lee KS, Pak CS, Sun CH, Koh Y, Chang H. The molecular pathogenesis of Trichilemmal carcinoma. BMC Cancer 2020;20:516. [PMID: 32493317 DOI: 10.1186/s12885-020-07009-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Salih FM. Risk assessment of combined photogenotoxic effects of sunlight and food additives. Science of The Total Environment 2006;362:68-73. [DOI: 10.1016/j.scitotenv.2005.05.027] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
3 Hussein MR. The <i>TP53</i> Tumor Suppressor Gene and Melanoma Tumorigenesis: Is There a Relationship? Tumor Biol 2004;25:200-7. [DOI: 10.1159/000081103] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
4 Daniotti M, Oggionni M, Ranzani T, Vallacchi V, Campi V, Di Stasi D, Torre GD, Perrone F, Luoni C, Suardi S, Frattini M, Pilotti S, Anichini A, Tragni G, Parmiani G, Pierotti MA, Rodolfo M. BRAF alterations are associated with complex mutational profiles in malignant melanoma. Oncogene 2004;23:5968-77. [DOI: 10.1038/sj.onc.1207780] [Cited by in Crossref: 149] [Cited by in F6Publishing: 127] [Article Influence: 8.3] [Reference Citation Analysis]
5 Ponticelli C, Cucchiari D, Bencini P. Skin cancer in kidney transplant recipients. J Nephrol 2014;27:385-94. [PMID: 24809813 DOI: 10.1007/s40620-014-0098-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
6 Dahl C, Guldberg P. The genome and epigenome of malignant melanoma. APMIS 2007;115:1161-76. [PMID: 18042149 DOI: 10.1111/j.1600-0463.2007.apm_855.xml.x] [Cited by in Crossref: 108] [Cited by in F6Publishing: 96] [Article Influence: 7.7] [Reference Citation Analysis]
7 Li W, Sanki A, Karim RZ, Thompson JF, Soon Lee C, Zhuang L, McCarthy SW, Scolyer RA. The role of cell cycle regulatory proteins in the pathogenesis of melanoma. Pathology. 2006;38:287-301. [PMID: 16916716 DOI: 10.1080/00313020600817951] [Cited by in Crossref: 92] [Cited by in F6Publishing: 86] [Article Influence: 5.8] [Reference Citation Analysis]
8 Fritsche MK, Knopf A. The Tumor Suppressor p53 in Mucosal Melanoma of the Head and Neck. Genes (Basel) 2017;8:E384. [PMID: 29236030 DOI: 10.3390/genes8120384] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
9 Prasad ML. Update on pigmented lesions of the sinonasal tract. Head Neck Pathol 2007;1:50-4. [PMID: 20614282 DOI: 10.1007/s12105-007-0008-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
10 Campioni M, Santini D, Tonini G, Murace R, Dragonetti E, Spugnini EP, Baldi A. Role of Apaf-1, a key regulator of apoptosis, in melanoma progression and chemoresistance. Exp Dermatol 2005;14:811-8. [DOI: 10.1111/j.1600-0625.2005.00360.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 34] [Article Influence: 2.5] [Reference Citation Analysis]
11 Ragnarsson-Olding B, Platz A, Olding L, Ringborg U. p53 protein expression and TP53 mutations in malignant melanomas of sun-sheltered mucosal membranes versus chronically sun-exposed skin. Melanoma Res 2004;14:395-401. [PMID: 15457096 DOI: 10.1097/00008390-200410000-00010] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
12 Dahlgren L, Schedvins K, Kanter-Lewensohn L, Dalianis T, Ragnarsson-Olding BK. Human papilloma virus (HPV) is rarely detected in malignant melanomas of sun sheltered mucosal membranes. Acta Oncol 2005;44:694-9. [PMID: 16227159 DOI: 10.1080/02841860500247461] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 1.7] [Reference Citation Analysis]
13 Dai DL, Martinka M, Bush JA, Li G. Reduced Apaf-1 expression in human cutaneous melanomas. Br J Cancer. 2004;91:1089-1095. [PMID: 15305193 DOI: 10.1038/sj.bjc.6602092] [Cited by in Crossref: 39] [Cited by in F6Publishing: 28] [Article Influence: 2.2] [Reference Citation Analysis]
14 Giraud G, Ramqvist T, Ragnarsson-Olding B, Dalianis T. DNA from BK virus and JC virus and from KI, WU, and MC polyomaviruses as well as from simian virus 40 is not detected in non-UV-light-associated primary malignant melanomas of mucous membranes. J Clin Microbiol 2008;46:3595-8. [PMID: 18768658 DOI: 10.1128/JCM.01635-08] [Cited by in Crossref: 43] [Cited by in F6Publishing: 14] [Article Influence: 3.1] [Reference Citation Analysis]
15 Lund LP, Timmins GS. Melanoma, long wavelength ultraviolet and sunscreens: Controversies and potential resolutions. Pharmacology & Therapeutics 2007;114:198-207. [DOI: 10.1016/j.pharmthera.2007.01.007] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
16 Houben R, Hesbacher S, Schmid CP, Kauczok CS, Flohr U, Haferkamp S, Müller CS, Schrama D, Wischhusen J, Becker JC. High-level expression of wild-type p53 in melanoma cells is frequently associated with inactivity in p53 reporter gene assays. PLoS One 2011;6:e22096. [PMID: 21760960 DOI: 10.1371/journal.pone.0022096] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 3.8] [Reference Citation Analysis]
17 Widlund HR, Fisher DE. Potent p53-independent tumor suppressor activity of ARF in melanoma-genesis. Pigment Cell Res 2007;20:339-40. [PMID: 17850505 DOI: 10.1111/j.1600-0749.2007.00401.x] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
18 Rodolfo M, Daniotti M, Vallacchi V. Genetic progression of metastatic melanoma. Cancer Letters 2004;214:133-47. [DOI: 10.1016/j.canlet.2004.06.049] [Cited by in Crossref: 45] [Cited by in F6Publishing: 37] [Article Influence: 2.5] [Reference Citation Analysis]
19 Dias-Santagata D, Selim MA, Su Y, Peng Y, Vollmer R, Chłopik A, Tell-Marti G, Paral KM, Shalin SC, Shea CR, Puig S, Fernandez-Figueras MT, Biernat W, Ryś J, Marszalek A, Hoang MP. KIT mutations and CD117 overexpression are markers of better progression-free survival in vulvar melanomas. Br J Dermatol 2017;177:1376-84. [PMID: 28734009 DOI: 10.1111/bjd.15836] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
20 Lawrence NF, Hammond MR, Frederick DT, Su Y, Dias-santagata D, Deng A, Selim MA, Mahalingam M, Flaherty KT, Hoang MP. Ki-67, p53, and p16 expression, and G691S RET polymorphism in desmoplastic melanoma (DM): A clinicopathologic analysis of predictors of outcome. Journal of the American Academy of Dermatology 2016;75:595-602. [DOI: 10.1016/j.jaad.2016.04.059] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
21 Dai DL, Martinka M, Li G. Prognostic significance of activated Akt expression in melanoma: a clinicopathologic study of 292 cases. J Clin Oncol. 2005;23:1473-1482. [PMID: 15735123 DOI: 10.1200/jco.2005.07.168] [Cited by in Crossref: 199] [Cited by in F6Publishing: 100] [Article Influence: 11.7] [Reference Citation Analysis]
22 Berger MF, Garraway LA. Applications of genomics in melanoma oncogene discovery. Hematol Oncol Clin North Am 2009;23:397-414, vii. [PMID: 19464593 DOI: 10.1016/j.hoc.2009.03.005] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
23 Prasad ML, Patel SG, Busam KJ. Primary mucosal desmoplastic melanoma of the head and neck. Head Neck 2004;26:373-7. [DOI: 10.1002/hed.10384] [Cited by in Crossref: 43] [Cited by in F6Publishing: 29] [Article Influence: 2.4] [Reference Citation Analysis]
24 Yang HM, Hsiao SJ, Schaeffer DF, Lai C, Remotti HE, Horst D, Mansukhani MM, Horst BA. Identification of recurrent mutational events in anorectal melanoma. Mod Pathol. 2017;30:286-296. [PMID: 27739435 DOI: 10.1038/modpathol.2016.179] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 5.2] [Reference Citation Analysis]
25 Hahn HM, Lee KG, Choi W, Cheong SH, Myung KB, Hahn HJ. An updated review of mucosal melanoma: Survival meta-analysis. Mol Clin Oncol 2019;11:116-26. [PMID: 31281645 DOI: 10.3892/mco.2019.1870] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
26 Soussi T, Kato S, Levy PP, Ishioka C. Reassessment of theTP53 mutation database in human disease by data mining with a library ofTP53 missense mutations. Hum Mutat 2005;25:6-17. [DOI: 10.1002/humu.20114] [Cited by in Crossref: 100] [Cited by in F6Publishing: 101] [Article Influence: 5.6] [Reference Citation Analysis]
27 Herraiz C, Calvo F, Pandya P, Cantelli G, Rodriguez-Hernandez I, Orgaz JL, Kang N, Chu T, Sahai E, Sanz-Moreno V. Reactivation of p53 by a Cytoskeletal Sensor to Control the Balance Between DNA Damage and Tumor Dissemination. J Natl Cancer Inst 2016;108:djv289. [PMID: 26464464 DOI: 10.1093/jnci/djv289] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 4.4] [Reference Citation Analysis]
28 Heinzelmann-Schwarz VA, Nixdorf S, Valadan M, Diczbalis M, Olivier J, Otton G, Fedier A, Hacker NF, Scurry JP. A clinicopathological review of 33 patients with vulvar melanoma identifies c-KIT as a prognostic marker. Int J Mol Med 2014;33:784-94. [PMID: 24535703 DOI: 10.3892/ijmm.2014.1659] [Cited by in Crossref: 29] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
29 Lyu SM, Wu JY, Byun JY, Choi HY, Park SH, Choi YW. Expression of Phosphatase and Tensin Homologue, phospho-Akt, and p53 in Acral Benign and Malignant Melanocytic Neoplasms (Benign Nevi, Dysplastic Nevi, and Acral Melanomas). Ann Dermatol 2016;28:548-54. [PMID: 27746632 DOI: 10.5021/ad.2016.28.5.548] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
30 Gwosdz C, Scheckenbach K, Lieven O, Reifenberger J, Knopf A, Bier H, Balz V. Comprehensive analysis of the p53 status in mucosal and cutaneous melanomas. Int J Cancer 2006;118:577-82. [DOI: 10.1002/ijc.21366] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 2.1] [Reference Citation Analysis]
31 Jebain J, Siller A Jr, Gill P, Prieto VG, Tyring SK. Recurrence of mucosal melanoma in Li-Fraumeni syndrome: A follow-up of an index case. JAAD Case Rep 2021;10:31-3. [PMID: 33732843 DOI: 10.1016/j.jdcr.2021.02.008] [Reference Citation Analysis]
32 Tarasenko VI, Subota IIu, Kobzev VF, Konstantinov IuM. [Isolation of mitochondrial DNA binding proteins which are specific for maize cox1 promoter]. Mol Biol (Mosk) 2005;39:394-402. [PMID: 15981569 DOI: 10.1007/s11008-005-0054-4] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
33 Mikkelsen LH, Larsen A, von Buchwald C, Drzewiecki KT, Prause JU, Heegaard S. Mucosal malignant melanoma - a clinical, oncological, pathological and genetic survey. APMIS 2016;124:475-86. [DOI: 10.1111/apm.12529] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 5.3] [Reference Citation Analysis]
34 Seltenhammer MH, Sundström E, Meisslitzer-Ruppitsch C, Cejka P, Kosiuk J, Neumüller J, Almeder M, Majdic O, Steinberger P, Losert UM, Stöckl J, Andersson L, Sölkner J, Vetterlein M, Golovko A. Establishment and characterization of a primary and a metastatic melanoma cell line from Grey horses. In Vitro Cell Dev Biol Anim 2014;50:56-65. [PMID: 23982913 DOI: 10.1007/s11626-013-9678-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]